FindTrial
Sign In

Study about in vivo metabolism Shuanghuanglian injection

Study about in vivo metabolism Shuanghuanglian injection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015961
Enrollment
Unknown
Registered
2018-05-02
Start date
2018-05-07
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anaphylactoid reaction

Interventions

shuanghuanglian group:shuanghuanglian
lvyuansuan group:lvyuansuan

Sponsors

Beijing Shijitan hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
35 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Male aged 35 to 45 years; 2. With complications of Shuanghuanglian injection (upper respiratory tract infection by virus or bacteria, pneumonia, amygdalitis, pharyngitis, etc.); 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. no other diseases; 2. no participance other in vivo clinical trial within 6 months.

Design outcomes

Primary

MeasureTime frame
chlorogenic acid and its metabolites in vivo;—

Countries

China

Contacts

Public ContactDan Yan

Beijing Shijitan hospital, Capital Medical University

yd277@126.com+86 13488678873

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026